Neuroone Medical Technologies Corp (NMTC)

$0.86 +0.02 (2.97%)
Market Cap 44.63M
Revenue (ttm) 12.10M
Net Income (ttm) -3.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.83%
Debt to Equity Ratio 0.00
Volume 219,000
Avg Vol 299,804
Day's Range N/A - N/A
Shares Out 50.43M
Stochastic %K 39%
Beta 0.70
Analysts Strong Sell
Price Target $2.30

Company Profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-...

Industry: Medical Devices
Sector: Healthcare
Phone: 952 426 1383
Website: nmtc1.com
Address:
7599 Anagram Drive, Eden Prairie, United States
IncognitoBull
IncognitoBull Feb. 4 at 3:32 PM
$NMTC has an updated website
0 · Reply
IncognitoBull
IncognitoBull Feb. 4 at 2:30 PM
$NMTC need to know those Pharma partners soon Dave.
1 · Reply
Mquigley
Mquigley Feb. 3 at 11:21 PM
$NMTC the 1 to the 15 minute trend lines today.
0 · Reply
IncognitoBull
IncognitoBull Feb. 3 at 7:55 PM
$NMTC TN is known as the Suicide Disease....
1 · Reply
Toolbox54
Toolbox54 Feb. 3 at 5:15 PM
$NMTC This needs to close above $1 for 10 days in a row basically by the end of the month. Let’s start moving up.
2 · Reply
Airdvl
Airdvl Feb. 3 at 5:05 PM
$NMTC this should climb into earnings, which comes out within the next few weeks.It looks like. i'm in!
0 · Reply
IncognitoBull
IncognitoBull Feb. 3 at 3:27 PM
$NMTC still my favorite stock for long term gains, but the days traders aren't impressed and institutions are still watching for more FDA approvals
0 · Reply
Mquigley
Mquigley Feb. 3 at 1:01 AM
$NMTC The trend lines & prices of the lower time frames.
0 · Reply
IncognitoBull
IncognitoBull Jan. 30 at 1:24 PM
$NPCE if you believe in NPCE, you should also check out $NMTC competing tech, we are just getting to commercialization, but, our tech is targeting additional uses, brain, pain, and drug delivery. Ground floor prices vs a weighted top.
0 · Reply
IncognitoBull
IncognitoBull Jan. 30 at 1:09 PM
$NMTC when it is slow, I look at other companies that might have competing tech. Neuropace has an implant device for epilepsy. It monitors for seizures and then "zaps" or stimulates the brain. Their website indicates its for one or two spots, only one device, one use. 33M o/s. 100M in annual revenue. Our device for multiple uses....brain, pain, and drug delivery. We will get there too.
1 · Reply
Latest News on NMTC
NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

Dec 17, 2025, 11:19 AM EST - 7 weeks ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NeuroOne Medical Technologies Corporation - Special Call

Oct 7, 2025, 10:55 AM EDT - 4 months ago

NeuroOne Medical Technologies Corporation - Special Call

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

Sep 8, 2025, 4:05 PM EDT - 5 months ago

NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Aug 18, 2025, 8:30 AM EDT - 6 months ago

NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript

Aug 14, 2025, 9:45 AM EDT - 6 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

Aug 14, 2025, 7:30 AM EDT - 6 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

Jul 31, 2025, 12:12 PM EDT - 6 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

Jul 31, 2025, 8:30 AM EDT - 6 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

Jul 23, 2025, 8:30 AM EDT - 7 months ago

NeuroOne® Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Jun 23, 2025, 8:30 AM EDT - 8 months ago

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

Jun 3, 2025, 8:30 AM EDT - 8 months ago

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

May 29, 2025, 1:05 PM EDT - 8 months ago

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript

May 13, 2025, 9:46 AM EDT - 9 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

May 13, 2025, 7:30 AM EDT - 9 months ago

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

May 12, 2025, 8:30 AM EDT - 9 months ago

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

May 5, 2025, 4:01 PM EDT - 9 months ago

NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

May 1, 2025, 9:55 AM EDT - 9 months ago

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Apr 23, 2025, 9:00 AM EDT - 10 months ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® Issues Letter to Shareholders

Apr 16, 2025, 9:00 AM EDT - 10 months ago

NeuroOne® Issues Letter to Shareholders

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Apr 14, 2025, 9:00 AM EDT - 10 months ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Apr 4, 2025, 12:57 PM EDT - 10 months ago

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

Apr 4, 2025, 8:30 AM EDT - 10 months ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Apr 3, 2025, 4:05 PM EDT - 10 months ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

Mar 18, 2025, 1:12 PM EDT - 11 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

Mar 18, 2025, 9:00 AM EDT - 11 months ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

Mar 18, 2025, 8:46 AM EDT - 11 months ago

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Mar 11, 2025, 9:00 AM EDT - 11 months ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 5, 2025, 9:00 AM EST - 1 year ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

Feb 12, 2025, 10:18 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

Feb 12, 2025, 8:00 AM EST - 1 year ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Feb 5, 2025, 11:00 AM EST - 1 year ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

Feb 4, 2025, 10:56 AM EST - 1 year ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Jan 10, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Stock Picks From Seeking Alpha's December 2024 New Analysts

Jan 7, 2025, 8:00 AM EST - 1 year ago

Stock Picks From Seeking Alpha's December 2024 New Analysts

ALGM CE CEG DOCS ETD FDVV FSS

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Jan 3, 2025, 8:30 AM EST - 1 year ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript

Dec 17, 2024, 9:42 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Dec 17, 2024, 8:30 AM EST - 1 year ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead

Dec 10, 2024, 3:15 AM EST - 1 year ago

NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Nov 13, 2024, 9:30 AM EST - 1 year ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

Oct 31, 2024, 4:01 PM EDT - 1 year ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

Sep 24, 2024, 9:30 AM EDT - 1 year ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Sep 10, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 6:23 PM EDT - 1 year ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

Aug 14, 2024, 7:21 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14, 2024, 4:00 PM EDT - 1 year ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Aug 12, 2024, 11:30 AM EDT - 1 year ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

Jun 20, 2024, 9:30 AM EDT - 1 year ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

May 14, 2024, 9:48 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 14, 2024, 4:00 PM EDT - 1 year ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

May 10, 2024, 2:43 PM EDT - 1 year ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

IncognitoBull
IncognitoBull Feb. 4 at 3:32 PM
$NMTC has an updated website
0 · Reply
IncognitoBull
IncognitoBull Feb. 4 at 2:30 PM
$NMTC need to know those Pharma partners soon Dave.
1 · Reply
Mquigley
Mquigley Feb. 3 at 11:21 PM
$NMTC the 1 to the 15 minute trend lines today.
0 · Reply
IncognitoBull
IncognitoBull Feb. 3 at 7:55 PM
$NMTC TN is known as the Suicide Disease....
1 · Reply
Toolbox54
Toolbox54 Feb. 3 at 5:15 PM
$NMTC This needs to close above $1 for 10 days in a row basically by the end of the month. Let’s start moving up.
2 · Reply
Airdvl
Airdvl Feb. 3 at 5:05 PM
$NMTC this should climb into earnings, which comes out within the next few weeks.It looks like. i'm in!
0 · Reply
IncognitoBull
IncognitoBull Feb. 3 at 3:27 PM
$NMTC still my favorite stock for long term gains, but the days traders aren't impressed and institutions are still watching for more FDA approvals
0 · Reply
Mquigley
Mquigley Feb. 3 at 1:01 AM
$NMTC The trend lines & prices of the lower time frames.
0 · Reply
IncognitoBull
IncognitoBull Jan. 30 at 1:24 PM
$NPCE if you believe in NPCE, you should also check out $NMTC competing tech, we are just getting to commercialization, but, our tech is targeting additional uses, brain, pain, and drug delivery. Ground floor prices vs a weighted top.
0 · Reply
IncognitoBull
IncognitoBull Jan. 30 at 1:09 PM
$NMTC when it is slow, I look at other companies that might have competing tech. Neuropace has an implant device for epilepsy. It monitors for seizures and then "zaps" or stimulates the brain. Their website indicates its for one or two spots, only one device, one use. 33M o/s. 100M in annual revenue. Our device for multiple uses....brain, pain, and drug delivery. We will get there too.
1 · Reply
IncognitoBull
IncognitoBull Jan. 30 at 12:39 PM
$NMTC not much going on, wish we'd hear of the pharmas testing the tech for drug delivery.
1 · Reply
Mquigley
Mquigley Jan. 30 at 12:32 AM
$NMTC lower time frames to the 15 minute trending lines & prices
0 · Reply
IncognitoBull
IncognitoBull Jan. 29 at 3:44 PM
$NMTC added
0 · Reply
peepthestamp
peepthestamp Jan. 29 at 12:57 PM
$NMTC
0 · Reply
Mquigley
Mquigley Jan. 29 at 12:17 AM
$NMTC The lower trend lines 1 to the 15 minute all trending upward.
0 · Reply
byecell
byecell Jan. 28 at 5:31 PM
$NMTC started position...
0 · Reply
MMM_invest
MMM_invest Jan. 28 at 3:28 PM
$NMTC
0 · Reply
MMM_invest
MMM_invest Jan. 28 at 3:20 PM
$NMTC
0 · Reply
IncognitoBull
IncognitoBull Jan. 28 at 1:40 PM
$NMTC $$ I only cry when an animal dies....
0 · Reply
GateWatch
GateWatch Jan. 28 at 1:47 AM
$NMTC
0 · Reply
texmade2
texmade2 Jan. 27 at 8:09 PM
$NMTC ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
0 · Reply
texmade2
texmade2 Jan. 27 at 6:26 AM
$NMTC GOING UP?
0 · Reply